» Articles » PMID: 39759201

Cytisine As an Emerging Tool for Smoking Cessation and Addiction Treatment

Overview
Date 2025 Jan 6
PMID 39759201
Authors
Affiliations
Soon will be listed here.
References
1.
Zatonski W, Cedzynska M, Tutka P, West R . An uncontrolled trial of cytisine (Tabex) for smoking cessation. Tob Control. 2006; 15(6):481-4. PMC: 2563682. DOI: 10.1136/tc.2006.016097. View

2.
Phusahat P, Dilokthornsakul P, Boonsawat W, Zaeoue U, Hansuri N, Tawinkan N . Efficacy and Safety of Cytisine in Combination with a Community Pharmacists' Counselling for Smoking Cessation in Thailand: A Randomized Double-Blinded Placebo-Controlled Trial. Int J Environ Res Public Health. 2022; 19(20). PMC: 9603285. DOI: 10.3390/ijerph192013358. View

3.
Campagnari S, Casari R, Zamboni L, Fusina F, Lugoboni F . Cytisine induced urticaria : a case report during a smoking cessation treatment. Acta Biomed. 2022; 93(S1):e2022073. PMC: 10510958. DOI: 10.23750/abm.v93iS1.12450. View

4.
Rigotti N, Benowitz N, Prochaska J, Leischow S, Nides M, Blumenstein B . Cytisinicline for Smoking Cessation: A Randomized Clinical Trial. JAMA. 2023; 330(2):152-160. PMC: 10336611. DOI: 10.1001/jama.2023.10042. View

5.
Walker N, Smith B, Barnes J, Verbiest M, Parag V, Pokhrel S . Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial. Addiction. 2021; 116(10):2847-2858. PMC: 8519028. DOI: 10.1111/add.15489. View